nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Dry skin—Epirubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Perflutren—Arrhythmia—Docetaxel—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Perflutren—Dyspnoea—Gemcitabine—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Perflutren—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Fatigue—Irinotecan—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Paraesthesia—Fluorouracil—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Pruritus—Sunitinib—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Pain—Irinotecan—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Perflutren—Dyspnoea—Fluorouracil—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Perflutren—Face oedema—Doxorubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Perflutren—Erythema—Docetaxel—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Perflutren—Dyspepsia—Fluorouracil—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Nausea—Tamoxifen—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Fatigue—Gemcitabine—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Cardiac arrest—Doxorubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Pain—Gemcitabine—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Nausea—Erlotinib—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Diarrhoea—Sunitinib—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Dysgeusia—Docetaxel—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Feeling abnormal—Irinotecan—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Back pain—Docetaxel—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Pain—Fluorouracil—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Muscle spasms—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Eosinophilia—Epirubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Dry skin—Doxorubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Dizziness—Sunitinib—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Perflutren—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Perflutren—Abdominal pain—Irinotecan—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Body temperature increased—Irinotecan—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Vomiting—Sunitinib—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Body temperature increased—Gemcitabine—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Rash—Sunitinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Dermatitis—Sunitinib—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Urticaria—Fluorouracil—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Headache—Sunitinib—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Syncope—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Leukopenia—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Body temperature increased—Fluorouracil—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Palpitations—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Loss of consciousness—Docetaxel—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Cough—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Hypersensitivity—Irinotecan—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Convulsion—Docetaxel—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Hypertension—Docetaxel—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Chest pain—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Arthralgia—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Myalgia—Docetaxel—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Nausea—Sunitinib—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Asthenia—Irinotecan—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Conjunctivitis—Epirubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Perflutren—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Dry mouth—Docetaxel—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Asthenia—Gemcitabine—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000994	0.000994	CcSEcCtD
Perflutren—Oedema—Docetaxel—pancreatic cancer	0.000994	0.000994	CcSEcCtD
Perflutren—Pruritus—Gemcitabine—pancreatic cancer	0.000991	0.000991	CcSEcCtD
Perflutren—Diarrhoea—Irinotecan—pancreatic cancer	0.000984	0.000984	CcSEcCtD
Perflutren—Shock—Docetaxel—pancreatic cancer	0.000978	0.000978	CcSEcCtD
Perflutren—Nervous system disorder—Docetaxel—pancreatic cancer	0.000975	0.000975	CcSEcCtD
Perflutren—Pruritus—Fluorouracil—pancreatic cancer	0.000975	0.000975	CcSEcCtD
Perflutren—Tachycardia—Docetaxel—pancreatic cancer	0.00097	0.00097	CcSEcCtD
Perflutren—Skin disorder—Docetaxel—pancreatic cancer	0.000966	0.000966	CcSEcCtD
Perflutren—Bradycardia—Epirubicin—pancreatic cancer	0.000961	0.000961	CcSEcCtD
Perflutren—Diarrhoea—Gemcitabine—pancreatic cancer	0.000959	0.000959	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000954	0.000954	CcSEcCtD
Perflutren—Dizziness—Irinotecan—pancreatic cancer	0.000951	0.000951	CcSEcCtD
Perflutren—Haemoglobin—Epirubicin—pancreatic cancer	0.000949	0.000949	CcSEcCtD
Perflutren—Rhinitis—Epirubicin—pancreatic cancer	0.000946	0.000946	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000946	0.000946	CcSEcCtD
Perflutren—Haemorrhage—Epirubicin—pancreatic cancer	0.000944	0.000944	CcSEcCtD
Perflutren—Diarrhoea—Fluorouracil—pancreatic cancer	0.000942	0.000942	CcSEcCtD
Perflutren—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000939	0.000939	CcSEcCtD
Perflutren—Pharyngitis—Epirubicin—pancreatic cancer	0.000937	0.000937	CcSEcCtD
Perflutren—Hypotension—Docetaxel—pancreatic cancer	0.000929	0.000929	CcSEcCtD
Perflutren—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000928	0.000928	CcSEcCtD
Perflutren—Vomiting—Irinotecan—pancreatic cancer	0.000914	0.000914	CcSEcCtD
Perflutren—Dizziness—Fluorouracil—pancreatic cancer	0.000911	0.000911	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—pancreatic cancer	0.00091	0.00091	CcSEcCtD
Perflutren—Rash—Irinotecan—pancreatic cancer	0.000907	0.000907	CcSEcCtD
Perflutren—Dermatitis—Irinotecan—pancreatic cancer	0.000906	0.000906	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000906	0.000906	CcSEcCtD
Perflutren—Headache—Irinotecan—pancreatic cancer	0.000901	0.000901	CcSEcCtD
Perflutren—Paraesthesia—Docetaxel—pancreatic cancer	0.000893	0.000893	CcSEcCtD
Perflutren—Vomiting—Gemcitabine—pancreatic cancer	0.000891	0.000891	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—pancreatic cancer	0.000889	0.000889	CcSEcCtD
Perflutren—Dyspnoea—Docetaxel—pancreatic cancer	0.000886	0.000886	CcSEcCtD
Perflutren—Rash—Gemcitabine—pancreatic cancer	0.000883	0.000883	CcSEcCtD
Perflutren—Dermatitis—Gemcitabine—pancreatic cancer	0.000883	0.000883	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—pancreatic cancer	0.000882	0.000882	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—pancreatic cancer	0.00088	0.00088	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—pancreatic cancer	0.000878	0.000878	CcSEcCtD
Perflutren—Headache—Gemcitabine—pancreatic cancer	0.000878	0.000878	CcSEcCtD
Perflutren—Flushing—Epirubicin—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Perflutren—Vomiting—Fluorouracil—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Perflutren—Dyspepsia—Docetaxel—pancreatic cancer	0.000875	0.000875	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—pancreatic cancer	0.000873	0.000873	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000869	0.000869	CcSEcCtD
Perflutren—Rash—Fluorouracil—pancreatic cancer	0.000869	0.000869	CcSEcCtD
Perflutren—Dermatitis—Fluorouracil—pancreatic cancer	0.000868	0.000868	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—pancreatic cancer	0.000867	0.000867	CcSEcCtD
Perflutren—Headache—Fluorouracil—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Perflutren—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000858	0.000858	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000858	0.000858	CcSEcCtD
Perflutren—Fatigue—Docetaxel—pancreatic cancer	0.000857	0.000857	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—pancreatic cancer	0.000856	0.000856	CcSEcCtD
Perflutren—Nausea—Irinotecan—pancreatic cancer	0.000854	0.000854	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—pancreatic cancer	0.000853	0.000853	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000851	0.000851	CcSEcCtD
Perflutren—Pain—Docetaxel—pancreatic cancer	0.00085	0.00085	CcSEcCtD
Perflutren—Chills—Epirubicin—pancreatic cancer	0.000847	0.000847	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—pancreatic cancer	0.000843	0.000843	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—pancreatic cancer	0.000842	0.000842	CcSEcCtD
Perflutren—Nausea—Gemcitabine—pancreatic cancer	0.000832	0.000832	CcSEcCtD
Perflutren—Erythema—Epirubicin—pancreatic cancer	0.000822	0.000822	CcSEcCtD
Perflutren—Feeling abnormal—Docetaxel—pancreatic cancer	0.000819	0.000819	CcSEcCtD
Perflutren—Nausea—Fluorouracil—pancreatic cancer	0.000818	0.000818	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—pancreatic cancer	0.000816	0.000816	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—pancreatic cancer	0.000814	0.000814	CcSEcCtD
Perflutren—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000813	0.000813	CcSEcCtD
Perflutren—Flushing—Doxorubicin—pancreatic cancer	0.000811	0.000811	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000811	0.000811	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—pancreatic cancer	0.000805	0.000805	CcSEcCtD
Perflutren—Back pain—Epirubicin—pancreatic cancer	0.000795	0.000795	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—pancreatic cancer	0.000792	0.000792	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—pancreatic cancer	0.00079	0.00079	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—pancreatic cancer	0.000789	0.000789	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Perflutren—Abdominal pain—Docetaxel—pancreatic cancer	0.000786	0.000786	CcSEcCtD
Perflutren—Body temperature increased—Docetaxel—pancreatic cancer	0.000786	0.000786	CcSEcCtD
Perflutren—Chills—Doxorubicin—pancreatic cancer	0.000784	0.000784	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—pancreatic cancer	0.00078	0.00078	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000762	0.000762	CcSEcCtD
Perflutren—Erythema—Doxorubicin—pancreatic cancer	0.00076	0.00076	CcSEcCtD
Perflutren—Agitation—Epirubicin—pancreatic cancer	0.000755	0.000755	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—pancreatic cancer	0.000745	0.000745	CcSEcCtD
Perflutren—Malaise—Epirubicin—pancreatic cancer	0.000741	0.000741	CcSEcCtD
Perflutren—Vertigo—Epirubicin—pancreatic cancer	0.000738	0.000738	CcSEcCtD
Perflutren—Syncope—Epirubicin—pancreatic cancer	0.000737	0.000737	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Perflutren—Back pain—Doxorubicin—pancreatic cancer	0.000735	0.000735	CcSEcCtD
Perflutren—Hypersensitivity—Docetaxel—pancreatic cancer	0.000733	0.000733	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—pancreatic cancer	0.000731	0.000731	CcSEcCtD
Perflutren—Palpitations—Epirubicin—pancreatic cancer	0.000726	0.000726	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—pancreatic cancer	0.000722	0.000722	CcSEcCtD
Perflutren—Cough—Epirubicin—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—pancreatic cancer	0.000717	0.000717	CcSEcCtD
Perflutren—Asthenia—Docetaxel—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Perflutren—Convulsion—Epirubicin—pancreatic cancer	0.000712	0.000712	CcSEcCtD
Perflutren—Hypertension—Epirubicin—pancreatic cancer	0.000709	0.000709	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000705	0.000705	CcSEcCtD
Perflutren—Pruritus—Docetaxel—pancreatic cancer	0.000703	0.000703	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—pancreatic cancer	0.0007	0.0007	CcSEcCtD
Perflutren—Myalgia—Epirubicin—pancreatic cancer	0.0007	0.0007	CcSEcCtD
Perflutren—Chest pain—Epirubicin—pancreatic cancer	0.0007	0.0007	CcSEcCtD
Perflutren—Agitation—Doxorubicin—pancreatic cancer	0.000699	0.000699	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000695	0.000695	CcSEcCtD
Perflutren—Discomfort—Epirubicin—pancreatic cancer	0.000691	0.000691	CcSEcCtD
Perflutren—Malaise—Doxorubicin—pancreatic cancer	0.000686	0.000686	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—pancreatic cancer	0.000684	0.000684	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—pancreatic cancer	0.000683	0.000683	CcSEcCtD
Perflutren—Syncope—Doxorubicin—pancreatic cancer	0.000682	0.000682	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Perflutren—Diarrhoea—Docetaxel—pancreatic cancer	0.00068	0.00068	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—pancreatic cancer	0.000672	0.000672	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Perflutren—Oedema—Epirubicin—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000668	0.000668	CcSEcCtD
Perflutren—Cough—Doxorubicin—pancreatic cancer	0.000663	0.000663	CcSEcCtD
Perflutren—Shock—Epirubicin—pancreatic cancer	0.00066	0.00066	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—pancreatic cancer	0.000659	0.000659	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—pancreatic cancer	0.000658	0.000658	CcSEcCtD
Perflutren—Dizziness—Docetaxel—pancreatic cancer	0.000657	0.000657	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—pancreatic cancer	0.000656	0.000656	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—pancreatic cancer	0.000654	0.000654	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—pancreatic cancer	0.000651	0.000651	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000648	0.000648	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—pancreatic cancer	0.000647	0.000647	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—pancreatic cancer	0.000647	0.000647	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—pancreatic cancer	0.000647	0.000647	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—pancreatic cancer	0.00064	0.00064	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—pancreatic cancer	0.000633	0.000633	CcSEcCtD
Perflutren—Vomiting—Docetaxel—pancreatic cancer	0.000632	0.000632	CcSEcCtD
Perflutren—Rash—Docetaxel—pancreatic cancer	0.000627	0.000627	CcSEcCtD
Perflutren—Hypotension—Epirubicin—pancreatic cancer	0.000627	0.000627	CcSEcCtD
Perflutren—Dermatitis—Docetaxel—pancreatic cancer	0.000626	0.000626	CcSEcCtD
Perflutren—Headache—Docetaxel—pancreatic cancer	0.000623	0.000623	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00062	0.00062	CcSEcCtD
Perflutren—Oedema—Doxorubicin—pancreatic cancer	0.00062	0.00062	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000611	0.000611	CcSEcCtD
Perflutren—Shock—Doxorubicin—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000609	0.000609	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—pancreatic cancer	0.000606	0.000606	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—pancreatic cancer	0.000603	0.000603	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—pancreatic cancer	0.000602	0.000602	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.0006	0.0006	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—pancreatic cancer	0.000598	0.000598	CcSEcCtD
Perflutren—Nausea—Docetaxel—pancreatic cancer	0.000591	0.000591	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—pancreatic cancer	0.00059	0.00059	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—pancreatic cancer	0.00058	0.00058	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000579	0.000579	CcSEcCtD
Perflutren—Fatigue—Epirubicin—pancreatic cancer	0.000578	0.000578	CcSEcCtD
Perflutren—Pain—Epirubicin—pancreatic cancer	0.000573	0.000573	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—pancreatic cancer	0.000557	0.000557	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—pancreatic cancer	0.000553	0.000553	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—pancreatic cancer	0.000553	0.000553	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000548	0.000548	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—pancreatic cancer	0.000546	0.000546	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000536	0.000536	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—pancreatic cancer	0.000535	0.000535	CcSEcCtD
Perflutren—Urticaria—Epirubicin—pancreatic cancer	0.000533	0.000533	CcSEcCtD
Perflutren—Pain—Doxorubicin—pancreatic cancer	0.000531	0.000531	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—pancreatic cancer	0.00053	0.00053	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000511	0.000511	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000507	0.000507	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—pancreatic cancer	0.000494	0.000494	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—pancreatic cancer	0.000493	0.000493	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—pancreatic cancer	0.000491	0.000491	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—pancreatic cancer	0.000491	0.000491	CcSEcCtD
Perflutren—Asthenia—Epirubicin—pancreatic cancer	0.000481	0.000481	CcSEcCtD
Perflutren—Pruritus—Epirubicin—pancreatic cancer	0.000474	0.000474	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—pancreatic cancer	0.000459	0.000459	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000457	0.000457	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—pancreatic cancer	0.000445	0.000445	CcSEcCtD
Perflutren—Dizziness—Epirubicin—pancreatic cancer	0.000443	0.000443	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Perflutren—Vomiting—Epirubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—pancreatic cancer	0.000425	0.000425	CcSEcCtD
Perflutren—Rash—Epirubicin—pancreatic cancer	0.000423	0.000423	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—pancreatic cancer	0.000422	0.000422	CcSEcCtD
Perflutren—Headache—Epirubicin—pancreatic cancer	0.00042	0.00042	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—pancreatic cancer	0.00041	0.00041	CcSEcCtD
Perflutren—Nausea—Epirubicin—pancreatic cancer	0.000398	0.000398	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—pancreatic cancer	0.000395	0.000395	CcSEcCtD
Perflutren—Rash—Doxorubicin—pancreatic cancer	0.000391	0.000391	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—pancreatic cancer	0.000391	0.000391	CcSEcCtD
Perflutren—Headache—Doxorubicin—pancreatic cancer	0.000389	0.000389	CcSEcCtD
Perflutren—Nausea—Doxorubicin—pancreatic cancer	0.000369	0.000369	CcSEcCtD
